[DOI] [PMC free article] [PubMed] [Google Scholar] 832.Qi L., Ke L., Liu X., Liao L., Ke S., Liu X
From a cost-effectiveness perspective, the metformin-tirzepatide combination makes strong economic sense
The authors have assessed a time correlation between ephedra consumption and 37 cases of stroke, half of which hemorrhagic, 10 cases of myocardial infarction and 11 cases of sudden death
The results hold because they were built on something not just subtracted from something
Incremental cost-effectiveness ratios (ICER) were calculated to express the incremental difference in costs and QALYs between semaglutide 2.4 mg and the D&E alternative
Disorders in brain metabolism and seizures may interact, exacerbating the condition